STOCKHOLM, October 8 — A long-term study published in the Journal of the American Academy of Child & Adolescent Psychiatry has found that individuals diagnosed with attention deficit hyperactivity disorder (ADHD) in childhood have more than four times the risk of developing cognitive impairment later in life compared to those without ADHD.
The research, led by scientists at the Karolinska Institutet in Sweden and involving collaborators from the University of California, Los Angeles (UCLA), analyzed data from over 13,000 participants born between 1980 and 1996 who were followed into their late 30s and early 40s. The study controlled for confounding factors including socioeconomic status, education level, comorbid psychiatric conditions such as depression and anxiety, and substance use.
Cognitive impairment was assessed using standardized neuropsychological tests measuring memory, executive function, and processing speed. Researchers reported that the hazard ratio for late-life cognitive impairment among those with childhood ADHD was 4.2 (95% confidence interval: 3.1–5.7), indicating a more than fourfold increased risk. The findings suggest ADHD may be a long-term risk factor for neurodegenerative processes, though the exact biological mechanisms remain under investigation.
Dr. Anna-Karin Olsson, the study’s lead author from the Karolinska Institutet, noted that the research adds to growing evidence that ADHD is not merely a childhood condition but may have enduring implications for brain health across the lifespan. Dr. Olsson emphasized that early intervention and sustained management of ADHD symptoms may play a role in mitigating long-term cognitive risks, though further research is needed to confirm preventive effects.
The study’s findings underscore the importance of continued investment in research and treatment for ADHD, particularly as the condition affects an estimated 5% of children and adolescents worldwide. As Dr. Olsson explained, “Understanding the long-term consequences of ADHD is crucial for developing effective strategies to support individuals with the disorder and improve their quality of life.” Consult your doctor for medical advice.
